Export

ATC codes: P01CB01
EMLc
Indication
Mucocutaneous leishmaniasis ICD11 code: 1F54.2
Medicine type
Chemical agent
List type
Core
Formulations
Parenteral > General injections > IM: 30% in 5 mL ampoule equivalent to approximately 8.1% antimony
EML status history
First added in 1987 (TRS 770)
Changed in 1989 (TRS 796)
Changed in 2002 (TRS 914)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
The 2007 recommendations of the EMLc Subcommittee for the listings of sodium stibogluconate and meglumine antimoniate were applied to the EML.